Paulo Amaral, GU Oncology Assistant Professor at Northwestern Feinberg School of Medicine, shared on X:
“Thrilled to present our multicenter study of >200 pts who had deferred CN after IO-based therapy. 13% with pCR, and 100% 18-month PFS. Preop tx duration and that nearly half stopped therapy after CN add important data for perioperative RCC space discussions.
Thanks to all participating sites and investigators – especially to Brian Rini, who mentored this work during my fellowship at Vanderbilt University Medical Center.”
You can also read ‘10 Must-Read Posts In GU Oncology This Week‘
